University of Minnesota Medical School physician researchers studied hydroxychloroquine as a treatment to prevent COVID-19 for those with high-risk for exposure to the virus—health care workers. The pre-exposure prophylaxis trial results, which were published in Clinical Infectious Diseases, determined that…
Read More
Coronavirus study to trial vaccine delivery through inhalers
A small coronavirus clinical study has been launched in the UK this week to explore the effects of delivering vaccines directly to the body’s airways using an inhaler. Imperial College London researchers said they will assess the safety and effectiveness…
Read More
Coronavirus: China millennials drink milk to boost immunity
One debate fuelled by the virus is about whether to have steamed buns and congee (porridge) for breakfast, or milk and toast. It’s a serious question in China, where the government is pushing people to drink milk to get more…
Read More
Covid-19: New coronavirus vaccine candidate induces immune response in mice, primates
Scientists, including one of Indian-origin, have developed a COVID-19 vaccine candidate, which they say generates antibodies that “potently neutralise” the novel coronavirus in mice and primates with a single immunisation. The researchers, including Amit Khandhar from the US-based biotech company…
Read More
Coronavirus: Hydroxychloroquine ineffective against mild Covid-19
The malaria drug touted by U.S. President Donald Trump as a COVID-19 treatment was ineffective for patients with a mild version of the disease in a study conducted by researchers at the University of Minnesota. About 24% of the patients…
Read More
Hydroxychloroquine shortages: when the enthusiasm for a potential cure affects patients
Amid initial public and scientific optimism for hydroxychloroquine (HCQ) as a potential treatment for COVID-19, health care professionals raised concerns about shortages of this inexpensive drug, which is widely used in the treatment of several rheumatic diseases such as arthritis….
Read More
‘No benefit’ from hydroxychloroquine for virus: UK trial
A major British trial of hydroxychloroquine has found it has “no benefit” for patients hospitalised with the coronavirus, researchers said Friday, announcing they had stopped tests of the drug. “We have concluded that there is no beneficial effect of hydroxychloroquine…
Read More